Patents by Inventor Andrew Abell

Andrew Abell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS AND COMPOUNDS FOR SAME
    Publication number: 20230139593
    Abstract: The present invention relates to the treatment of disorders associated with oxidative stress including neuropathic pain and small synthetically derived compounds for treating such disorders.
    Type: Application
    Filed: March 12, 2021
    Publication date: May 4, 2023
    Inventors: Thomas Avery, Andrew Abell, Dion Turner, Peter M. Grace, Jiahe Li
  • COMPOSITION AND METHOD FOR HIP1-TARGETING INHIBITOR COMPOUNDS
    Publication number: 20230001000
    Abstract: Provided herein is an inhibitor compound targeting Hip1, with the inhibitor compound comprising a tripeptide targeting sequence that directs the compound to the active site of Hip1 and a C-terminal electrophilic warhead conjugated to the targeting sequence, the warhead configured to inactive the enzyme.
    Type: Application
    Filed: May 28, 2022
    Publication date: January 5, 2023
    Inventors: Nathan E. Goldfarb, Andrew Abell, Nicholas Schumann, Borja Lopez Perez
  • Antimicrobial compounds
    Patent number: 9108978
    Abstract: A new class of biotin protein ligase (BPL) inhibitors that have antibacterial activity against multiple Staphylococcus aureus isolates, including clinically important methicillin-resistant S. aureus (MRSA) are disclosed that are non-toxic.
    Type: Grant
    Filed: September 21, 2012
    Date of Patent: August 18, 2015
    Assignees: Monash University, Adelaide Research & Innovation Pty Ltd
    Inventors: Andrew Abell, Steven Polyak, Grant Booker, John Wallace, Tatiana Soares da Costa, Angie Jarrad, William Tieu, Kelly Lee Keeling, Daniel Sejer Pedersen, Nicole Pendini, Matthew Wilce, Min Yin Yap
  • Compounds and compositions
    Publication number: 20070293560
    Abstract: The invention provides compounds of Formula I: The invention relates to compounds having enzyme inhibitory activity. It further relates to methods for preparing the compounds, compositions comprising them and their use in methods of treatment. Particularly, the invention relates to methods for the treatment or prophylaxis of diseases and disorders resulting from excessive calpain activity.
    Type: Application
    Filed: May 17, 2007
    Publication date: December 20, 2007
    Inventors: Andrew Abell, James Coxon, Shigeru Miyamoto, Matthew Jones, Axel Neffe, Steven Aitken, Blair Stuart, Janna Nikkel, James Morton, Roy Bickerstaffe, Lucinda Goodricke Robertson, Hannah Lee, Matthew Muir